Open-Label Study, Evaluating Patient Satisfaction and Symptom Improvement When Treating Male Hypogonadism With Natesto™
Clinical trial NCT02937740 · COMPLETED
Trial details
- NCT number
- NCT02937740
- Sponsor
- Acerus Pharmaceuticals Corporation
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-01
- Primary completion
- 2017-10-01
- Enrollment
- 117
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.